Non-typhoidal Salmonella combination vaccines: clinical development plan and regulatory considerations.
Excler J-L. et al, (2025), Vaccine, 62
Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study.
Al-Hakim A. et al, (2025), Lancet Rheumatol
The TyphiNET data visualisation dashboard: unlocking Salmonella Typhi genomics data to support public health
Dyson ZA. et al, (2025), Genome Medicine, 17
Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.
Ibarz-Pavon AB. et al, (2025), Vaccine, 56
Comparison of short- and long-term humoral immune responses to pneumococcal polysaccharide and glycoconjugate vaccines in an HIV-infected population.
Faustini SE. et al, (2024), The Journal of infection, 89
Optimizing Vaccine Trials for Enteric Diseases: The Enterics for Global Health (EFGH) <i>Shigella</i> Surveillance Study.
Vannice K. et al, (2024), Open forum infectious diseases, 11, S1 - S5
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops.
Baqar S. et al, (2024), Vaccine, 42, 1445 - 1453
Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries.
Giersing BK. et al, (2023), The Lancet. Global health, 11, e1819 - e1826
A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa.
Van Puyvelde S. et al, (2023), Nature communications, 14
Salmonella Combination Vaccines: Moving Beyond Typhoid
MacLennan CA. et al, (2023), Open Forum Infectious Diseases, 10, S58 - S66
Efficient Autotransporter-Mediated Extracellular Secretion of a Heterologous Recombinant Protein by Escherichia coli.
Beriotto I. et al, (2023), Microbiology spectrum, 11
Consequences of Shigella infection in young children: a systematic review.
Libby TE. et al, (2023), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 129, 78 - 95
Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data.
Cohen D. et al, (2023), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 29, 366 - 371
Severe anaemia, iron deficiency, and susceptibility to invasive bacterial infections
Abuga KM. et al, (2023), Wellcome Open Research, 8, 48 - 48
Complementary measurement of nontyphoidal Salmonella-specific IgG and IgA antibodies in oral fluid and serum.
Elias SC. et al, (2023), Heliyon, 9